Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
Jump to:
Preferred Name | Azaserine | |
Synonyms |
|
|
Definitions |
A naturally occurring serine derivative diazo compound with antineoplastic properties, Azaserine functions as a purine antagonist and glutamine analogue (glutamine amidotransferase inhibitor) that competitively inhibits pathways in which glutamine is metabolized. An antibiotic and antitumor agent, Azaserine is used in clinical studies as a potential antineoplastic agent. (NCI04) |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C289 |
|
CAS_Registry |
115-02-6
|
|
Chemical_Formula |
C5H7N3O4
|
|
code |
C289
|
|
Contributing_Source |
FDA
|
|
definition |
A naturally occurring serine derivative diazo compound with antineoplastic properties, Azaserine functions as a purine antagonist and glutamine analogue (glutamine amidotransferase inhibitor) that competitively inhibits pathways in which glutamine is metabolized. An antibiotic and antitumor agent, Azaserine is used in clinical studies as a potential antineoplastic agent. (NCI04)
|
|
FDA_UNII_Code |
87299V3Q9W
|
|
in_subset |
http://purl.obolibrary.org/obo/NCIT_C63923 http://purl.obolibrary.org/obo/NCIT_C177537 http://purl.obolibrary.org/obo/NCIT_C176424 http://purl.obolibrary.org/obo/NCIT_C128784 |
|
Is_Value_For_GDC_Property | ||
label |
Azaserine
|
|
Legacy Concept Name |
Azaserine
|
|
Maps_To |
Azaserine
|
|
NCI_Drug_Dictionary_ID |
39156
|
|
NSC Number |
742
|
|
PDQ_Closed_Trial_Search_ID |
39156
|
|
PDQ_Open_Trial_Search_ID |
39156
|
|
Preferred_Name |
Azaserine
|
|
prefixIRI |
NCIT:C289
|
|
prefLabel |
Azaserine
|
|
Semantic_Type |
Pharmacologic Substance Nucleic Acid, Nucleoside, or Nucleotide Antibiotic
|
|
UMLS_CUI |
C0004480
|
|
subClassOf |
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping